Registro:

Referencias:

• Brennan, P.J., Kumogai, T., Berezov, A., Murali, R., Greene, M.I., HER2/neu: Mechanisms of dimerization/oligomerization (2000) Oncogene, 19 (53), pp. 6093-6101. , DOI 10.1038/sj.onc.1203967
• Graus-Porta, D., Beerli, R.R., Daly, J.M., Hynes, N.E., ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling (1997) EMBO Journal, 16 (7), pp. 1647-1655. , DOI 10.1093/emboj/16.7.1647
• Olayioye, M.A., Graus-Porta, D., Beerli, R.R., Rohrer, J., Gay, B., Hynes, N.E., ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner (1998) Molecular and Cellular Biology, 18 (9), pp. 5042-5051
• Olayioye, M.A., Neve, R.M., Lane, H.A., Hynes, N.E., The ErbB signaling network: Receptor heterodimerization in development and cancer (2000) EMBO Journal, 19 (13), pp. 3159-3167
• Olayioye, M.A., Update on HER-2 as a target for cancer therapy. Intracellular signaling pathways of ErbB2/HER-2 and family members (2002) Breast Cancer Res, 2001, pp. 385-389
• Slamon, D.J., Clark, G., Wong, S., Levin, W., Ullrich, A., McGuire, W., Human breast cancer: Correlation of relapse and survival with amplification of the HER2/neu oncogene (1986) Science, 235, pp. 177-182
• Graus-Porta, D., Beerli, R.R., Hynes, N.E., Single-chain antibody-mediated intracellular retention of erbB2 impairs neu differentiation factor and epidermal growth factor signaling (1995) Mol Cell Biol, 15, pp. 1182-1191
• Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Yarden, Y., ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer (1996) EMBO Journal, 15 (2), pp. 254-264
• Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Yarden, Y., Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions (1996) EMBO Journal, 15 (10), pp. 2452-2467
• Aigner, A., Juhl, H., Malerczyk, C., Tkybusch, A., Benz, C.C., Czubayko, F., Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation (2001) Oncogene, 20 (17), pp. 2101-2111. , DOI 10.1038/sj.onc.1204305
• Scott, G.K., Robles, R., Park, J.W., Montgomery, P.A., Daniel, J., Holmes, W.E., Lee, J., Benz, C.C., A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells (1993) Molecular and Cellular Biology, 13 (4), pp. 2247-2257
• Katoh, M., Yazaki, Y., Sugimura, T., Terada, M., c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase (1993) Biochemical and Biophysical Research Communications, 192 (3), pp. 1189-1197. , DOI 10.1006/bbrc.1993.1542
• McMahan, C.J., Slack, J.L., Mosley, B., Cosman, D., Lupton, S.D., Brunton, L.L., Grubin, C.E., Sims, J.E., A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types (1991) EMBO Journal, 10 (10), pp. 2821-2832
• Huber, S., Braun, G., Burger-Kentischer, A., Reinhart, B., Luckow, B., Horster, M., CFTR mRNA and its truncated splice variant (TRN-CFTR) are differentially expressed during collecting duct ontogeny (1998) FEBS Letters, 423 (3), pp. 362-366. , DOI 10.1016/S0014-5793(98)00112-4, PII S0014579398001124
• Zabrecky, J.R., Lam, T., McKenzie, S.J., Carney, W., The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3 (1991) Journal of Biological Chemistry, 266 (3), pp. 1716-1720
• Lin, Y.J., Clinton, G.M., A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells (1991) Oncogene, 6 (4), pp. 639-643
• Pupa, S.M., Menard, S., Morelli, D., Pozzi, B., De Palo, G., Colnaghi, M.I., The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage (1993) Oncogene, 8 (11), pp. 2917-2923
• Codony-Servat, J., Albanell, J., Lopez-Talavera, J.C., Arribas, J., Baselga, J., Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells (1999) Cancer Research, 59 (6), pp. 1196-1201
• Doherty, J.K., Bond, C., Jardim, A., Adelman, J.P., Clinton, G.M., The HER-2/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor (1999) Proceedings of the National Academy of Sciences of the United States of America, 96 (19), pp. 10869-10874. , DOI 10.1073/pnas.96.19.10869
• Pagano, E., Calvo, J.C., ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes (2003) Journal of Cellular Biochemistry, 90 (3), pp. 561-572. , DOI 10.1002/jcb.10647
• Pagano, E., Coso, O., Calvo, J.C., Down-modulation of erbB2 activity is necessary but not enough in the differentiation of 3T3-L1 preadipocytes (2008) J Cell Biochem, 104, pp. 274-285
• Chomczynski, P., Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction (1987) Analytical Biochemistry, 162 (1), pp. 156-159. , DOI 10.1006/abio.1987.9999
• Lim, H., Dey, S.K., Das, S.K., Differential expression of the erbB2 gene in the periimplantation mouse uterus: Potential mediator of signaling by epidermal growth factor-like growth factors (1997) Endocrinology, 138 (3), pp. 1328-1337. , DOI 10.1210/en.138.3.1328
• Press, M.F., Cordon-Cardo, C., Slamon, D.J., Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues (1990) Oncogene, 5, pp. 953-962
• Schroeder, J.A., Lee, D.C., Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland (1998) Cell Growth and Differentiation, 9 (6), pp. 451-464
• Stern, D.F., Kamps, M.P., EGF-stimulated tyrosine phosphorylation of p185neu: A potential model for receptor interactions (1998) EMBO J, 7, pp. 995-1001
• Schmidt, W., Pöll-Jordan, G., Löffler, G., Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor-1, corticosterone, and cyclic AMP (1990) J Biol Chem, 265, pp. 15489-15495
• Reed, B.C., Kaufmann, S.H., Mackall, J.C., Alterations in insulin binding accompanying differentiation of 3T3-L1 preadipocytes (1977) Proceedings of the National Academy of Sciences of the United States of America, 74 (11), pp. 4876-4880
• Serrero, G., Mills, D., Physiological role of epidermal growth factor on adipose tissue development in vivo (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (9), pp. 3912-3916
• Adachi, H., Kurachi, H., Homma, H., Adachi, K., Takashi, I., Morishige, K., Matsuzawa, Y., Miyake, A., Epidermal growth factor promotes adipogenesis of 3T3-L1 cell in vitro (1994) Endocrinology, 135, pp. 1824-1830
• Hardy, R., Gupta, K., MacDonald, J., Williford, J., Wells, A., Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes (1995) Endocrinology, 136, pp. 431-439
• Sundaresan, S., Roberts, P.E., King, K.L., Sliwkowski, M.X., Mather, J.P., Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression (1998) Endocrinology, 139 (12), pp. 4756-4764
• Colomer, R., Montero, S., Lluch, A., Ojeda, B., Barnadas, A., Casado, A., Massuti, B., Lloveras, B., Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer (2000) Clinical Cancer Research, 6 (6), pp. 2356-2362
• Gebhardt, F., Zanker, K.S., Brandt, B., Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients (1998) Biochemical and Biophysical Research Communications, 247 (2), pp. 319-323. , DOI 10.1006/bbrc.1998.8779
• O'Rourke, D., Nute, E., Davis, J., Wu, C., Lee, A., Murali, R., Zhang, H., Greene, M.I., Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: Implications for subdomain contributions to receptor assembly (1998) Oncogene, 16, pp. 1197-1202
• Basu, A., Raghunath, M., Bishayee, S., Das, M., Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: Role for interreceptor interaction in kinase regulation (1989) Molecular and Cellular Biology, 9 (2), pp. 671-677
• Citri, A., Skaria, K.B., Yarden, Y., The deaf and the dumb: The biology of ErbB-2 and ErbB-3 (2003) Experimental Cell Research, 284 (1), pp. 54-65. , DOI 10.1016/S0014-4827(02)00101-5
• Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P., Kraus, M.H., Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas (1995) Oncogene, 10, pp. 1813-1821
• Lee, H., Maihle, N.J., Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues (1998) Oncogene, 16 (25), pp. 3243-3252
• Lee, H., Akita, R.W., Sliwkowski, M.X., Maihle, N.J., A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4 (2001) Cancer Research, 61 (11), pp. 4467-4473
• Darcy, K.M., Zangani, D., Wohlhueter, A.L., Huang, R.-Y., Vaughan, M.M., Russell, J.A., Ip, M.M., Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cells (2000) Journal of Histochemistry and Cytochemistry, 48 (1), pp. 63-80
• Kainulainen, V., Sundvall, M., Maatta, J.A., Santiestevan, E., Klagsbrun, M., Elenius, K., A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis (2000) Journal of Biological Chemistry, 275 (12), pp. 8641-8649. , DOI 10.1074/jbc.275.12.8641
• Junttila, T.T., Sundvall, M., Maatta, J.A., Elenius, K., ErbB4 and its isoformsselective regulation of growth factor responses by naturally occurring receptor variants (2000) Trends in Cardiovascular Medicine, 10 (7), pp. 304-310. , DOI 10.1016/S1050-1738(01)00065-2, PII S1050173801000652

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------